Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Viracta Therapeutics

Explore full profile

Viracta is committed to advancing new medicines based on its viral activation therapy approach to benefit patients

Encinitas, United StatesFounded 2016Biotech & Life Sciences
Revenue $2.1M Latest reported FY
Total funding $50–100M Disclosed equity funding

About Viracta Therapeutics

Viracta Therapeutics is a precision oncology company focused on developing innovative therapies for virus-associated malignancies, such as Epstein-Barr Virus (EBV) associated lymphomas. The company operates in the biotechnology and pharmaceutical market, primarily serving patients with viral-associated cancers and other serious diseases. Viracta's business model revolves around the research, development, and commercialization of targeted treatments. The company generates revenue through the sale of its proprietary drugs and potential licensing agreements with other pharmaceutical companies. By leveraging its expertise in oncology and virology, Viracta aims to address unmet medical needs and improve patient outcomes.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Encinitas, United States
Listing
IPO 2021
Sector
Biotech & Life Sciences

Latest news

Press, funding announcements and product moves mentioning Viracta Therapeutics.

See all news

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • NantKwest
  • Forward Ventures
  • Latterell Venture Partners
  • Wicklow Capital
  • Shenzhen Salubris Pharmaceuticals

Series B and later4 investors entered at this stage

Talent

Book a demo to see the people
Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Encinitas HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Viracta Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viracta Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles